glp 1 for ms patients GLP-1 Targets Progression, ㅤ, Neuraly dosed the first patient in a Phase 2 TAG-MS trial of NLY01, a long acting GLP-1 receptor agonist being evaluated in progressive multiple sclerosis. The 96 week GLP-1 values at individual OGTT
Pay in 4 interest-free payments of $6.63 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11

























